Home › Funds › Avidity Partners Management LP › CATX

Avidity Partners Management LP position in CATX

PERSPECTIVE THERAPEUTICS INC · Health Care

Avidity Partners Management LP reported holding 6,299,999 shares of CATX (PERSPECTIVE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.5M, representing 3.44% of its reported portfolio and ranking #6 among its reported holdings. Avidity Partners Management LP has disclosed CATX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)6.30M sh
Reported value held$21.48M
Portfolio Weight3.44%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Avidity Partners Management LP's CATX position evolved

Avidity Partners Management LP first disclosed a stake in CATX in Q2 2024 at 3,037,668 shares (US$30.3M). The position peaked in Q3 2024 at 3,444,002 shares, worth US$46.0M. Across 9 filings, Avidity Partners Management LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,299,999 shares valued at US$21.5M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 61% increase in Q3 2025 (shares fell 20% over the following quarter), a 88% increase in Q1 2026 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 3.04M $30.29M New
Q3 2024 3.44M $45.98M Add
Q4 2024 2.69M $8.60M Reduce
Q1 2025 2.20M $4.68M Reduce
Q2 2025 1.86M $6.39M Reduce
Q3 2025 2.99M $10.27M Add
Q4 2025 3.21M $8.83M Add
Q1 2026 6.05M $25.23M Add
Q2 2026 6.30M $21.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CATX and 13F data

CATX (PERSPECTIVE THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CATX — the largest reported positions include TCG Crossover Management, LLC (US$27.0M), Commodore Capital LP (US$21.6M), Affinity Asset Advisors, LLC (US$14.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CATX

All CATX fund holders →

FAQ

How long has Avidity Partners Management LP held CATX?

Avidity Partners Management LP has disclosed CATX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Avidity Partners Management LP's current position in CATX?

As of Q2 2026, Avidity Partners Management LP holds 6.30M shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $21.48M, representing 3.44% of its reported portfolio and ranking #6.

Has Avidity Partners Management LP been buying or selling CATX?

In the latest 13F filing (Q2 2026), Avidity Partners Management LP increased its position in CATX. The position peaked in Q3 2024 at 3.44M shares.

Which other funds hold CATX?

Other major institutional holders of CATX include TCG Crossover Management, LLC, Commodore Capital LP, Affinity Asset Advisors, LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.